The Thousand Oaks, Calif.-based biotech pharmaceutical company makes drugs that treat patients in nearly 100 countries.
Company Info
| CEO | Robert A. Bradway |
| CEO Title | Chairman & Chief Executive Officer |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| HQ Location | Thousand Oaks, CA |
| Website | www.amgen.com |
| Years on Fortune 500 List | 18 |
| Employees | 19,200 |
Key Financials (Last Fiscal Year)
| Revenues ($M) | $22,991 |
| Profits ($M) | $7,722 |
| Assets ($M) | $77,626 |
| Total Stockholder Equity ($M) | $29,875 |
| Market Value — as of March 31, 2017 ($M) | $120,830 |
Profit Ratios
| Profit as % of Revenues | 33.6% |
| Profits as % of Assets | 9.9% |
| Profits as % of Stockholder Equity | 25.8% |
Earnings Per Share (Last Fiscal Year)
| Earnings Per Share ($) | 10 |
| EPS % Change (from 2015) | 13% |
| EPS % Change (5 year annual rate) | 20.4% |
| EPS % Change (10 year annual rate) | 15.2% |
Total Return
| Total Return to Investors (2016) | -7.5% |
| Total Return to Investors (5 year, annualized) | 20.3% |
| Total Return to Investors (10 year, annualized) | 9.1% |
